Showing results (81-90 of 295) with videos related to

Sort By:
Pageof 30
American Journal of Physiology. Lung Cellular and Molecular Physiology|September 13, 2002
Mitogen-activated protein kinases regulate HO-1 gene transcription after ischemia-reperfusion lung injuryXuchen Zhang, Eric L Bedard, Richard Potter, et al.
Expert Opinion on Medical Diagnostics|March 15, 2013
MammaPrint 70-gene profile quantifies the likelihood of recurrence for early breast cancerPhilippe L Bedard, Stella Mook, Martine J Piccart-Gebhart, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|August 16, 2003
Biotransformation of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) in peripheral human lung microsomesGraeme B J Smith, John R Bend, Leanne L Bedard, et al.
Current Oncology (Toronto, Ont.)|December 31, 2020
A population-based study of pulmonary monitoring and toxicity for patients with testicular cancer treated with bleomycinM J Raphael, M D Lougheed, X Wei, et al.
Urologic Oncology|November 28, 2018
Delivery of chemotherapy for testicular cancer in routine practice: A population-based studySafiya Karim, Xuejiao Wei, Michael J Leveridge, et al.
Biodegradation|January 1, 1996
Aerobic degradation of polychlorinated biphenyls by Alcaligenes sp. JB1: metabolites and enzymesL C Commandeur, R J May, H Mokross, et al.
British Journal of Cancer|December 21, 2021
No evidence of disease versus residual disease in long-term responders to first-line HER2-targeted therapy for metastatic breast cancerZachary Veitch, Domen Ribnikar, Derek Tilley, et al.
British Journal of Cancer|November 18, 2010
Identification of a low-risk subgroup of HER-2-positive breast cancer by the 70-gene prognosis signatureM Knauer, F Cardoso, J Wesseling, et al.
Journal of Oncology|September 5, 2015
Right Ventricular Dysfunction in Patients Experiencing Cardiotoxicity during Breast Cancer TherapyAnna Calleja, Frédéric Poulin, Ciril Khorolsky, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 25, 2015
Prospective Evaluation of the 21-Gene Recurrence Score Assay for Breast Cancer Decision-Making in OntarioMark N Levine, Jim A Julian, Philippe L Bedard, et al.
Pageof 30